Grant: Doctoral: Vanier Canada Graduate Scholarships
McGill University
$150,000.00
Functional connectivity of resting state activity as a neuroimaging biomarker for Alzheimer's disease
EF 2011-12
Résumé
With an aging population, Canada faces a pervasive increase in Alzheimer's disease (AD). Although known to cause intellectual decline and dysfunction, AD is poorly understood. Biomarkers currently used to diagnose AD capture limited aspects of the disease at particular timepoints, usually well after brain tissue has significantly deteriorated. Prior to the detection of AD, healthy brain regions appear to initially compensate for dysfunction and gradual deterioration in diseased regions. By using brain imaging technology to identify these initial adaptations, we may develop a valuable biomarker for AD.
Neuroimaging methods non-invasively measure brain activity. From these measures we can quantify relationships between different brain areas. Regions that interact in synchrony are defined as networks. In past AD research, this method relied on identifying a priori regions for analysis. Using a novel data-driven approach, I will investigate as yet unexplored brain regions to determine the connection between changes in brain networks and different stages of AD development. Comparing healthy controls with AD patients, I will also measure the functional, structural and vascular changes associated with these variations.
From this method I anticipate developing a successful classification system for different phases of AD pathogenesis. Since this analysis is data driven and not directed by a priori assumptions, I also anticipate that related neurophysiological changes will be discovered in unexpected brain regions.
My goal is to identify an effective brain imaging biomarker for Alzheimer's disease. The benefit is early diagnosis of AD and the identification of associated neurophysiological changes. This will facilitate the development and effectiveness of treatment interventions. This method may also lay the groundwork for future research on other poorly understood illnesses. Most importantly, however, my research addresses a critical health issue facing Canadians.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
247715
Name
Dickinson Philip G
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Functional connectivity of resting state activity as a neuroimaging biomarker for Alzheimer's disease
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Aging; Alzheimer'S Disease; Biomarkers; Brain Networks; Fmri; Functional Connectivity; Functional Magnetic Resonance Imaging; Neuroimaging; Resting State
Abstract
With an aging population, Canada faces a pervasive increase in Alzheimer's disease (AD). Although known to cause intellectual decline and dysfunction, AD is poorly understood. Biomarkers currently used to diagnose AD capture limited aspects of the disease at particular timepoints, usually well after brain tissue has significantly deteriorated. Prior to the detection of AD, healthy brain regions appear to initially compensate for dysfunction and gradual deterioration in diseased regions. By using brain imaging technology to identify these initial adaptations, we may develop a valuable biomarker for AD.
Neuroimaging methods non-invasively measure brain activity. From these measures we can quantify relationships between different brain areas. Regions that interact in synchrony are defined as networks. In past AD research, this method relied on identifying a priori regions for analysis. Using a novel data-driven approach, I will investigate as yet unexplored brain regions to determine the connection between changes in brain networks and different stages of AD development. Comparing healthy controls with AD patients, I will also measure the functional, structural and vascular changes associated with these variations.
From this method I anticipate developing a successful classification system for different phases of AD pathogenesis. Since this analysis is data driven and not directed by a priori assumptions, I also anticipate that related neurophysiological changes will be discovered in unexpected brain regions.
My goal is to identify an effective brain imaging biomarker for Alzheimer's disease. The benefit is early diagnosis of AD and the identification of associated neurophysiological changes. This will facilitate the development and effectiveness of treatment interventions. This method may also lay the groundwork for future research on other poorly understood illnesses. Most importantly, however, my research addresses a critical health issue facing Canadians.
Competitiondate
201111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dickinson, Philip G
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~